BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21426020)

  • 1. The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.
    Denny WA; Palmer BD
    Future Med Chem; 2010 Aug; 2(8):1295-304. PubMed ID: 21426020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.
    Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS
    Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.
    Somasundaram S; Anand RS; Venkatesan P; Paramasivan CN
    BMC Microbiol; 2013 Oct; 13():218. PubMed ID: 24083570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
    Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases.
    Showalter HD
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.
    Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH
    FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
    Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
    J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
    Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
    Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
    Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
    J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver.
    Dogra M; Palmer BD; Bashiri G; Tingle MD; Shinde SS; Anderson RF; O'Toole R; Baker EN; Denny WA; Helsby NA
    Br J Pharmacol; 2011 Jan; 162(1):226-36. PubMed ID: 20955364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity.
    Tawari NR; Degani MS
    Chem Biol Drug Des; 2011 Sep; 78(3):408-17. PubMed ID: 21689377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure and biological evaluation of novel bicyclic nitroimidazole derivatives.
    Zaprutko L; Zwawiak J; Augustynowicz-Kopeć E; Zwolska Z; Bartoszak-Adamska E; Nowicki W
    Arch Pharm (Weinheim); 2012 Jun; 345(6):463-7. PubMed ID: 22266946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pyrimidines as Antitubercular Agents.
    Inoyama D; Paget SD; Russo R; Kandasamy S; Kumar P; Singleton E; Occi J; Tuckman M; Zimmerman MD; Ho HP; Perryman AL; Dartois V; Connell N; Freundlich JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311070
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of nitrite from the antitubercular nitroimidazole drug PA-824 and analogues upon one-electron reduction in protic, non-aqueous solvent.
    Maroz A; Shinde SS; Franzblau SG; Ma Z; Denny WA; Palmer BD; Anderson RF
    Org Biomol Chem; 2010 Jan; 8(2):413-8. PubMed ID: 20066278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis.
    Patterson S; Wyllie S; Stojanovski L; Perry MR; Simeons FR; Norval S; Osuna-Cabello M; De Rycker M; Read KD; Fairlamb AH
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4699-706. PubMed ID: 23856774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
    Shalini ; Viljoen A; Kremer L; Kumar V
    Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Thompson AM; Blaser A; Anderson RF; Shinde SS; Franzblau SG; Ma Z; Denny WA; Palmer BD
    J Med Chem; 2009 Feb; 52(3):637-45. PubMed ID: 19099398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.
    Hartkoorn RC; Ryabova OB; Chiarelli LR; Riccardi G; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2014 May; 58(5):2944-7. PubMed ID: 24550336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
    J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PA-824.
    Tuberculosis (Edinb); 2008 Mar; 88(2):134-6. PubMed ID: 18486052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.